cyclazocine - CISMeF

Preferred Label : cyclazocine;

MeSH definition : An analgesic with mixed narcotic agonist-antagonist properties.;

MeSH CAS label : 2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-;

MeSH Related Number : 3572-80-3 (Cyclazocine);

Registry Number MeSH : 3572-80-3;

Wikipedia link : https://en.wikipedia.org/wiki/Cyclazocine;

Codes EINECS : 222-689-9;

Is substance : O;

UNII : J5W1B1159C;

InChIKey : YQYVFVRQLZMJKJ-UHFFFAOYSA-N;

Details

Origin ID

D003496;

UMLS CUI

C0010526;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cyclazocine [ICHI extension code]
CISMeF manual mappings
- cyclazocine [Substance BNPC]
Currated CISMeF NLP mapping
- Cyclazocine [ICD-11 Extension code]
- Cyclazocine [NCIt concept]
Pharmacological action(s)
- analgesics, non-narcotic [MeSH Descriptor]
- narcotic antagonists [MeSH Descriptor]
Record concept(s)
- cyclazocine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 3-(cyclopropylmethyl)-6-ethyl-1,2,3,4,5,6-hexahydro-11-methyl-N-(2-(1,1'-biphenyl)-4-ylethyl)-1-oxo-2,6-methano-3-benazocine-8-carboxamide [MeSH Supplementary Concept]
- 6,11-dimethyl-1,2,3,4,5,6-hexahydro-3-((2'-(methoxycarbonyl)-2'-phenylcyclopropyl)methyl)-2,6-methano-3-benzazocin-8-ol [MeSH Supplementary Concept]
- 8-aminocyclazocine [MeSH Supplementary Concept]
- 8-carboxamidocyclazocine [MeSH Supplementary Concept]
- BC 2860 [MeSH Supplementary Concept]
- N-(2-(4'-methoxy(1,1'-biphenyl)-4-yl)ethyl)-8-carboxamidocyclazocine [MeSH Supplementary Concept]
- N-(3-fluoropropyl)-N-normetazocine [MeSH Supplementary Concept]
- N-(4-isothiocyanatobenzyl)-N-normetazocine [MeSH Supplementary Concept]
- N-benzylnormetazocine [MeSH Supplementary Concept]
- UM 1046 [MeSH Supplementary Concept]
- UM 747 [MeSH Supplementary Concept]
- UM-1037 [MeSH Supplementary Concept]
- deoxy-N-benzylnormetazocine [MeSH Supplementary Concept]
- eptazocine [MeSH Supplementary Concept]
- normetazocine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cyclazocine [ICD-11 Extension code]
- Cyclazocine [NCIt concept]
- cyclazocine [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients